PCV133 THE COST-EFFECTIVENESS OF GENOTYPING CYP2C19 TO GUIDE ANTIPLATELET THERAPY SELECTION

May 1, 2010, 00:00
10.1016/S1098-3015(10)72851-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)72851-5/fulltext
Title : PCV133 THE COST-EFFECTIVENESS OF GENOTYPING CYP2C19 TO GUIDE ANTIPLATELET THERAPY SELECTION
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72851-5&doi=10.1016/S1098-3015(10)72851-5
First page :
Section Title :
Open access? : No
Section Order : 422
Categories :
Tags :
Regions :
ViH Article Tags :